Karyopharm Therapeutics Inc. Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value
Karyopharm Therapeutics Inc. (KPTI) had Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value of $63.80 million as of 2019-12-31, per its 10-K filed 2020-02-26.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue · last filed 2020-02-26
- 2019-12-31: Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value $63.80M.
- 2019-09-30: Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value $23.10M.
- 2019-06-30: Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value $19.71M.
- 2019-03-31: Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value $57.12M.
| Period end | Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value | Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value as first filed |
|---|---|---|
| 2019-12-31 | $63.80M 10-K · filed 2020-02-26 | |
| 2019-09-30 | $23.10M 10-Q · filed 2019-11-04 | |
| 2019-06-30 | $19.71M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $57.12M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $180.60M 10-K · filed 2020-02-26 | $180.63M 10-K · filed 2019-02-28 |
| 2018-09-30 | $81.22M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $96.84M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $91.55M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $96.62M 10-K · filed 2019-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |